Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsThe Bill & Melinda Gates Foundation has renewed its long-standing partnership with Indonesia following a high-profile visit by Bill Gates to Jakarta in early May. While the Foundation emphasized its commitment to improving public health and healthcare access in the country, one initiative in particular—trials for a novel tuberculosis (TB) vaccine—has attracted growing public skepticism and concern.
Some Indonesian netizens oppose the clinical trial of a tuberculosis (TB) vaccine candidate in Indonesia, whose development has been supported by the Gates Foundation. They claim that the state is selling people as "lab rats" for the philanthropist’s agenda.
The government has scaled up efforts against tuberculosis by empowering local communities and strengthening health facilities down to the village and subdistrict levels for the early detection and treatment of the world’s deadliest infectious disease.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.